Perimenopause is one of the most significant and least discussed hormonal transitions in a woman's life. It typically begins in the mid-to-late forties, though it can start in the late thirties for some women, and lasts an average of 4-8 years. Understanding what is happening physiologically, recognizing the wide range of symptoms, and knowing what options exist for management can transform this transition from confusing to navigated with knowledge and agency.
Perimenopause begins when the ovaries start producing less estrogen and progesterone in response to declining ovarian reserve. Unlike the gradual changes of younger adulthood, perimenopausal hormone levels are erratic — fluctuating widely between cycles and sometimes within a cycle. This volatility, rather than simply declining levels, produces many of the characteristic symptoms.
Menopause itself is defined as 12 consecutive months without a menstrual period. The average age of menopause in the US is 51, making the typical perimenopause window approximately ages 43-51.
Hot flashes and night sweats affect approximately 75% of women during perimenopause. A hot flash involves a sudden sensation of intense heat, often spreading from the chest to the face, accompanied by sweating and flushing. Night sweats are hot flashes occurring during sleep and can severely disrupt sleep quality.
Cycles may become shorter, then longer, then unpredictable. Periods may be heavier or lighter. Any bleeding between periods, very heavy bleeding, or bleeding after a period of amenorrhea should be evaluated.
Both night sweats and primary insomnia increase during perimenopause. Progesterone's sleep-promoting effects diminish, estrogen's protective effect on slow-wave sleep declines, and the biological clock becomes less robust.
Memory lapses, difficulty with word retrieval, and reduced concentration are commonly reported during perimenopause. Research supports a real, measurable decline in verbal memory and processing speed during the perimenopausal transition, which typically improves after menopause.
Declining estrogen causes vaginal tissue to thin, dry, and become less elastic — changes that can cause vaginal dryness, discomfort, and painful sex. The urethra and bladder are also estrogen-sensitive, contributing to increased urinary urgency and frequency.
Hormone therapy is the most effective treatment for vasomotor symptoms and also addresses sleep, mood, cognitive, bone, and genitourinary symptoms. For healthy women under 60 without specific contraindications, the current consensus from major menopause societies is that the benefits of hormone therapy generally outweigh the risks. This conversation belongs with a knowledgeable healthcare provider who can assess your individual risk profile.